Monitoring of the medical team involved in the care of Ebola patient concluded The Nigerian Ebola patient admitted to the Major Incident Hospital was declared cured 21 days ago.
Authority for Nuclear Safety and Radiation Protection (ANVS) gets off the ground 1 January saw the launch of the ANVS. The ANVS combines many of the Dutch government’s tasks in the field of nuclear safety and radiation protection in one independent authority.
Child at day care centre more likely to develop gastroenteritis Research carried out by RIVM and UMC Utrecht has shown that children who go to a day care centre are more likely to develop gastroenteritis (stomach flu).
12 percent fewer tuberculosis patients in comparison with 2012 In 2013, 848 patients with tuberculosis (TB) were reported. This was 109 TB patients (12%) less than in 2012. In the past decade, the number of TB patients in the Netherlands has fallen by 38%.
Concerns over whooping cough despite modifications to vaccination programme Modifications to the National Immunisation Programme have led to fewer cases of whooping cough among children.
Standards for three drugs in Dutch surface water RIVM proposes water quality standards for three drugs in surface water: carbamazepine (epilepsy), metoprolol (heart disease) and metformin (diabetes).
Safety of the nanomaterial SAS (silica) in food still uncertain Uncertainty still remains over the safety of the nanomaterial SAS in food. Food additive E551 consists of ‘synthetic amorphous silica’ (SAS) and is applied as an anti-caking agent.
Open and sustainable building for RIVM and MEB The Central Government Real Estate Agency has awarded the contract to build new premises for two knowledge institutes - RIVM and the MEB - to StruktonHurks.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.